CNS PHARMACEUTICALS AG Retains Jumpstart Marketing, Inc. to Launch Marketing Campaign

ZURICH, SWITZERLAND and NEW YORK, NY--(Marketwire - March 24, 2010) -

CNS Pharmaceuticals AG (FRANKFURT: C35) today announced that it entered into a marketing and distribution agreement with Jumpstart Marketing, Inc. CNS believes that Jumpstart’s efforts will increase CNS’s revenues, build brand awareness and improve distribution of MemorA-Z®, CNS’s memory enhancement supplement. Jumpstart specializes in assisting companies in gaining access to regional and mass market retailers through its network of sales representatives, media contacts and celebrity endorsements.

Samuel Weisberger, Chief Executive Officer of CNS, stated, “We are excited to have reached an agreement with Jumpstart Marketing to improve the distribution and sales of MemorA-Z. Jumpstart has a stellar reputation and has achieved success for its many clients. CNS is convinced that Jumpstart can help CNS capture significant market share in the memory enhancement supplement market and substantially increase CNS’s revenue. Jumpstart Marketing offers CNS a great opportunity to gain substantial exposure quickly for MemorA-Z, CNS’s unique, patented supplement. MemorA-Z has been tested in a clinical study. We are pleased to have formed this relationship with Jumpstart and are looking forward to a profitable future.”

“We are excited to have been retained by CNS. We have already started implementing CNS’s 2010 - 2011 marketing campaign,” said Richard Cotler, the President of Jumpstart Marketing. “Jumpstart Marketing anticipates having an immediate and positive impact on CNS’s market exposure and on consumer brand awareness of MemorA-Z. Jumpstart expects that its efforts will translate into a significant increase in CNS revenues in the short term.” Jumpstart has placed its clients into companies such as Kroger, Costco, Target and BJ’s. Additionally, Jumpstart has relationships with several sports teams, including the New York Yankees and the Cleveland Cavaliers.

About MemorA-Z:
MemorA-Z is a patented nutritional supplement developed by Dr. John Blass, MD, Ph.D., who was the first Chairman of the Joint Presidential-Congressional Panel on Alzheimer’s disease and Related Disorders. Dr. Blass is Professor Emeritus at Weill Medical College of Cornell University and has published over 300 articles and studies on understanding and improving brain function, especially for the aging and Alzheimer patients.

About CNS:
CNS Pharmaceuticals AG is based in Zurich, Switzerland, and is the parent of CNS Pharmaceuticals, Inc., a wholly owned Delaware subsidiary. CNS Pharmaceuticals AG is listed on the Frankfurt Exchange and trades under the symbol C35.